TipRanks
Go Ultimate55% OFF

Richard A. Miller Insider Profile

11 Followers

Richard A. Miller, President & CEO, Director at Corvus Pharmaceuticals, holds 2.33M shares in Corvus Pharmaceuticals (Ticker: CRVS), holds 626.93K shares in Pharmacyclics (Ticker: PCYC), holds ― shares in Bolt Biotherapeutics (Ticker: BOLT). Most recently, Richard A. Miller Bought ― shares of Corvus Pharmaceuticals on May 20, 2026 for an estimated value of $83.45K.

Richard A. Miller's Trading History

CRVS
Corvus Pharmaceuticals
May 20, 2026President & CEO, DirectorInformative Buy83.45K$23.39M
BOLT
Bolt Biotherapeutics
―Director――
PCYC
Pharmacyclics
――――

You May Also Like

Richard A. Miller insider profile FAQ

What is the percentage of profitable transactions made by Richard A. Miller?
The percentage of profitable transactions made by Richard A. Miller is 45%.
What is the average return per transaction made by Richard A. Miller?
The average return per transaction made by Richard A. Miller is 19.50%.
What stocks does Richard A. Miller hold?
Richard A. Miller holds: CRVS, PCYC, BOLT stocks.
What was Richard A. Miller’s latest transaction?
Richard A. Miller’s latest transaction was an Informative Buy of $83.45K.
What was Richard A. Miller's most profitable transaction?
Richard A. Miller’s most profitable transaction was an Informative Buy of CRVS stock on June 6, 2022. The return on the trade was 238.20%.
What is Richard A. Miller's role in Corvus Pharmaceuticals?
Richard A. Miller's role in Corvus Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.